Literature DB >> 20956834

Quality-of-life issues in patients with ductal carcinoma in situ.

Patricia A Ganz1.   

Abstract

Ductal carcinoma in situ (DCIS) as we know it today is a clinical entity that is primarily discovered through the finding of microscopic calcifications on a screening mammogram. Asymptomatic women who are found to have DCIS receive treatments that are similar to women with invasive breast cancer and experience substantial psychological distress in spite of having an excellent prognosis and normal life expectancy. More research is needed to determine the best way to communicate with women about this condition and to match the extent of treatment with the risk of serious future disease. Clinical and research efforts should focus on reducing the anxiety and psychological distress associated with the diagnosis of DCIS.

Entities:  

Mesh：

Year:  2010        PMID： 20956834      PMCID： PMC5161073          DOI： 10.1093/jncimonographs/lgq029

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN： 1052-6773


  21 in total

1.  Quality of life in patients with ductal carcinoma in situ of the breast treated with conservative surgery and postoperative irradiation.

Authors:  M Amichetti; O Caffo; M Arcicasa; M Roncadin; O Lora; A Rigon; G Zini; L Armaroli; F Coghetto; P Zorat; S Neri; N Teodorani
Journal:  Breast Cancer Res Treat       Date:  1999-03       Impact factor: 4.872

Review 2.  Ductal carcinoma in situ of the breast.

Authors:  Harold J Burstein; Kornelia Polyak; Julia S Wong; Susan C Lester; Carolyn M Kaelin
Journal:  N Engl J Med       Date:  2004-04-01       Impact factor: 91.245

3.  Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Authors:  Victor G Vogel; Joseph P Costantino; D Lawrence Wickerham; Walter M Cronin; Reena S Cecchini; James N Atkins; Therese B Bevers; Louis Fehrenbacher; Eduardo R Pajon; James L Wade; André Robidoux; Richard G Margolese; Joan James; Scott M Lippman; Carolyn D Runowicz; Patricia A Ganz; Steven E Reis; Worta McCaskill-Stevens; Leslie G Ford; V Craig Jordan; Norman Wolmark
Journal:  JAMA       Date:  2006-06-05       Impact factor: 56.272

4.  Breast cancer classification: time for a change.

Authors:  Umberto Veronesi; Stefano Zurrida; Aron Goldhirsch; Nicole Rotmensz; Giuseppe Viale
Journal:  J Clin Oncol       Date:  2009-04-20       Impact factor: 44.544

5.  Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ.

Authors:  L G Bluman; N A Borstelmann; B K Rimer; J D Iglehart; E P Winer
Journal:  J Womens Health Gend Based Med       Date:  2001 Jul-Aug

Review 6.  Screening for breast cancer: an update for the U.S. Preventive Services Task Force.

Authors:  Heidi D Nelson; Kari Tyne; Arpana Naik; Christina Bougatsos; Benjamin K Chan; Linda Humphrey
Journal:  Ann Intern Med       Date:  2009-11-17       Impact factor: 25.391

7.  Psychological distress and physical health in the year after diagnosis of DCIS or invasive breast cancer.

Authors:  Sophie Lauzier; Elizabeth Maunsell; Pascale Levesque; Myrto Mondor; Jean Robert; André Robidoux; Louise Provencher
Journal:  Breast Cancer Res Treat       Date:  2009-08-04       Impact factor: 4.872

8.  Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery.

Authors:  Larissa Nekhlyudov; Laurel A Habel; Ninah S Achacoso; Inkyung Jung; Reina Haque; Laura C Collins; Stuart J Schnitt; Charles P Quesenberry; Suzanne W Fletcher
Journal:  J Clin Oncol       Date:  2009-05-11       Impact factor: 44.544

9.  Perceptions and management approaches of physicians who care for women with ductal carcinoma in situ.

Authors:  Ann Partridge; Jeffrey P Winer; Mehra Golshan; Jennifer R Bellon; Emily Blood; E Claire Dees; Ebonie Sampson; Karen M Emmons; Eric Winer
Journal:  Clin Breast Cancer       Date:  2008-06       Impact factor: 3.225

Review 10.  Evaluation of the current knowledge limitations in breast cancer research: a gap analysis.

Authors:  Alastair Thompson; Keith Brennan; Angela Cox; Julia Gee; Diana Harcourt; Adrian Harris; Michelle Harvie; Ingunn Holen; Anthony Howell; Robert Nicholson; Michael Steel; Charles Streuli
Journal:  Breast Cancer Res       Date:  2008-03-27       Impact factor: 6.466
View more
  11 in total

1.  Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.

Authors:  Patricia A Ganz; Reena S Cecchini; Thomas B Julian; Richard G Margolese; Joseph P Costantino; Laura A Vallow; Kathy S Albain; Patrick W Whitworth; Mary E Cianfrocca; Adam M Brufsky; Howard M Gross; Gamini S Soori; Judith O Hopkins; Louis Fehrenbacher; Keren Sturtz; Timothy F Wozniak; Thomas E Seay; Eleftherios P Mamounas; Norman Wolmark
Journal:  Lancet       Date:  2015-12-11       Impact factor: 79.321

2.  Health behavior change following a diagnosis of ductal carcinoma in situ: An opportunity to improve health outcomes.

Authors:  Amy M Berkman; Amy Trentham-Dietz; Kim Dittus; Vicki Hart; Christine M Vatovec; John G King; Ted A James; Susan G Lakoski; Brian L Sprague
Journal:  Prev Med       Date:  2015-04-06       Impact factor: 4.018

3.  Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis.

Authors:  Marc D Ryser; Mathias Worni; Elizabeth L Turner; Jeffrey R Marks; Rick Durrett; E Shelley Hwang
Journal:  J Natl Cancer Inst       Date:  2015-12-17       Impact factor: 13.506

Review 4.  Prediction Models and Decision Aids for Women with Ductal Carcinoma In Situ: A Systematic Literature Review.

Authors:  Renée S J M Schmitz; Erica A Wilthagen; Frederieke van Duijnhoven; Marja van Oirsouw; Ellen Verschuur; Thomas Lynch; Rinaa S Punglia; E Shelley Hwang; Jelle Wesseling; Marjanka K Schmidt; Eveline M A Bleiker; Ellen G Engelhardt
Journal:  Cancers (Basel)       Date:  2022-07-02       Impact factor: 6.575

Review 5.  Effect of age and race on quality of life in young breast cancer survivors.

Authors:  Phuong Khanh Morrow; Anita C Broxson; Mark F Munsell; Karen Basen-Enquist; Carol K Rosenblum; Leslie R Schover; Lynne H Nguyen; Limin Hsu; Lilibeth Castillo; Karin M Hahn; Jennifer K Litton; Danielle N Kwiatkowski; Gabriel N Hortobagyi
Journal:  Clin Breast Cancer       Date:  2013-10-25       Impact factor: 3.225

6.  Trends in Health-Related Quality of Life After a Diagnosis of Ductal Carcinoma In Situ.

Authors:  Vicki Hart; Brian L Sprague; Susan G Lakoski; John M Hampton; Polly A Newcomb; Ronald E Gangnon; Amy Trentham-Dietz
Journal:  J Clin Oncol       Date:  2016-02-16       Impact factor: 44.544

7.  The association between post-diagnosis health behaviors and long-term quality of life in survivors of ductal carcinoma in situ: a population-based longitudinal cohort study.

Authors:  Vicki Hart; Amy Trentham-Dietz; Amy Berkman; Mayo Fujii; Christopher Veal; John Hampton; Ronald E Gangnon; Polly A Newcomb; Susan C Gilchrist; Brian L Sprague
Journal:  Qual Life Res       Date:  2018-02-07       Impact factor: 4.147

8.  Disease-free survival by treatment after a DCIS diagnosis in a population-based cohort study.

Authors:  Brian L Sprague; Vicki McLaughlin; John M Hampton; Polly A Newcomb; Amy Trentham-Dietz
Journal:  Breast Cancer Res Treat       Date:  2013-08-25       Impact factor: 4.872

9.  Risk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effect.

Authors:  Alexander Liede; Mona Cai; Tamara Fidler Crouter; Daniela Niepel; Fiona Callaghan; D Gareth Evans
Journal:  Breast Cancer Res Treat       Date:  2018-05-28       Impact factor: 4.872

Review 10.  Ductal carcinoma in situ: to treat or not to treat, that is the question.

Authors:  Maartje van Seijen; Esther H Lips; Alastair M Thompson; Serena Nik-Zainal; Andrew Futreal; E Shelley Hwang; Ellen Verschuur; Joanna Lane; Jos Jonkers; Daniel W Rea; Jelle Wesseling
Journal:  Br J Cancer       Date:  2019-07-09       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.